These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy. Nygaard B; Specht L Lancet; 1998 Mar; 351(9104):725-6. PubMed ID: 9504522 [No Abstract] [Full Text] [Related]
3. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator. Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552 [No Abstract] [Full Text] [Related]
4. [The role of radiotherapy in Graves' ophthalmopathy]. Jaulerry C J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286 [TBL] [Abstract][Full Text] [Related]
5. Attempt at thyroid ablation with radioactive iodine for the treatment of ophthalmopathy in Graves' disease. Fawell WN; Catz B Am J Med Sci; 1973 Jun; 265(6):467-72. PubMed ID: 4740469 [No Abstract] [Full Text] [Related]
6. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Kinyoun JL; Kalina RE; Brower SA; Mills RP; Johnson RH Arch Ophthalmol; 1984 Oct; 102(10):1473-6. PubMed ID: 6548374 [TBL] [Abstract][Full Text] [Related]
7. Does radioiodine cause the ophthalmopathy of Graves' disease? McDougall IR Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998 [No Abstract] [Full Text] [Related]
11. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy. Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428 [TBL] [Abstract][Full Text] [Related]
12. The use of independent collimation in the treatment of Graves' ophthalmopathy. Snow A Br J Radiol; 1999 Apr; 72(856):389-91. PubMed ID: 10474501 [TBL] [Abstract][Full Text] [Related]
13. Orbital radiotherapy for Graves' ophthalmopathy. Bartalena L; Marcocci C; Pinchera A J Clin Endocrinol Metab; 2004 Jan; 89(1):13-4. PubMed ID: 14715819 [No Abstract] [Full Text] [Related]
14. Graves' ophthalmopathy--a clinical review. Carter JN Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168 [TBL] [Abstract][Full Text] [Related]
15. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study. Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988 [TBL] [Abstract][Full Text] [Related]
17. [Long-term follow-up results of ocular damages after radiation therapy in maxillar cancer (author's transl)]. Yoshioka H; Kawashima K Nippon Ganka Gakkai Zasshi; 1977 Aug; 81(8):1190-4. PubMed ID: 930780 [No Abstract] [Full Text] [Related]
18. The role of radiation therapy in Graves' ophthalmopathy. Chowdhury AD; Moriarty MJ Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904 [TBL] [Abstract][Full Text] [Related]
19. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy. Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A Exp Clin Endocrinol; 1991 May; 97(2-3):332-7. PubMed ID: 1915652 [No Abstract] [Full Text] [Related]